Radiation Oncology/Therapy: Page 15

Navidea to sell $8M milestone payment

By AuntMinnie.com staff writers

Navidea Biopharmaceuticals plans to sell an $8 million milestone payment it has received and to seek a $2.75 million equity line of credit.

April 27, 2023

Accuray touts Q3 2023 revenue gains

By AuntMinnie.com staff writers

Accuray is reporting revenue increases for its third quarter 2023.

April 26, 2023

PET/CT reveals different reactions to COVID-19 vaccines

By Will Morton

PET/CT imaging shows that COVID-19 mRNA vaccines appear to cause higher rates of reactive lymph nodes in cancer patients compared with whole-virus vaccines, according to a study presented at the American Roentgen Ray Society meeting in Honolulu.

April 26, 2023

ASTRO, ESTRO issue guidelines for lung cancer therapy

By AuntMinnie.com staff writers

The American Society for Radiation Oncology (ASTRO) and the European Society for Radiotherapy and Oncology (ESTRO) have issued guidance on the use of definitive local therapy to treat patients with oligometastatic non-small cell lung cancer.

April 25, 2023

Is special labeling needed for radioactive specimens?

By Will Morton

Special labeling and shipping precautions for radioactive sentinel lymph node (SLN) specimens may not be necessary in hospitals, according to a study published April 21 in the Journal of Medical Imaging and Radiation Science.

April 25, 2023

Lantheus secures FDA fast track designation for prostate cancer drug

By AuntMinnie.com staff writers

Lantheus Medical Imaging parent company Lantheus Holdings and partner Point Biopharma Global have secured fast-track designation from the U.S. Food and Drug Administration (FDA) for lutetium-177 PNT2002, a radiopharmaceutical for the treatment of metastatic, castration-resistant prostate cancer.

April 23, 2023

New MRI technique helps target ultrasound-guided prostate biopsy

By Kate Madden Yee

A new microstructure imaging technique, hybrid multidimensional MRI (HM-MRI), could enable better targeting of areas in the prostate that need to be biopsied, according to a presentation at the American Roentgen Ray Society annual meeting in Honolulu.

April 23, 2023

Viewray posts 2023 Q1 revenue increases

By AuntMinnie.com staff writers

Viewray posted revenue increases in its first quarter and outlined strategic business alternatives it is exploring to "maximize shareholder value."

April 12, 2023

FDA clears Fusion's targeted alpha therapy

By AuntMinnie.com staff writers

Fusion Pharmaceuticals has secured clearance from the U.S. Food and Drug Administration (FDA) for its radiopharmaceuticals actinium-225-FPI-2068 and corresponding imaging analog Indium-111-FPI-2107.

April 12, 2023

How effective is micro-CT for assessing breast tumor margins?

By Kate Madden Yee

Micro-CT shows promise as an additional tool to standard-of-care assessment of tumor margins during breast-conserving surgery, according to a study published April 11 in the Annals of Surgical Oncology.

April 12, 2023

ImaginAB licenses immuno-PET tracer to Leucid

By AuntMinnie.com staff writers

Immuno-PET developer ImaginAB has licensed its zirconium-89 crefmirlimab berdoxam radiotracer to biotech company Leucid for use in studies of solid tumors.

April 11, 2023

China authorizes Qi Kang Medical Technology to open new facility

By AuntMinnie.com staff writers

The Department of Ecology and Environment of Jiangsu Province in China has authorized Eckert & Ziegler subsidiary Qi Kang Medical Technology to construct a radioisotope production facility in Jintan.

April 11, 2023

Previous Page

Page 15 of 466

Next Page